SCHEMBL23913446

SCHEMBL23913446

c1ccc(-c2ccc3oc4cc(-c5nc(-c6ccc(-n7c8ccccc8c8ccccc87)cc6)nc(-c6ccc7c(c6)oc6ccccc67)n5)ccc4c3c2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 3/20 0.39
PLA2G4A P47712 3/20 0.39
KDM4E B2RXH2 3/20 0.39
ATM Q13315 2/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
CHEK2 O96017 1/20 0.38
MMP12 P39900 2/20 0.37
MMP13 P45452 1/20 0.37
HCRTR1 O43613 1/20 0.36
PTGER4 P35408 1/20 0.35
PLA2G10 O15496 1/20 0.35
PTPN1 P18031 1/20 0.35
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
AHR P35869 2/20 0.35
MEN1 O00255 2/20 0.35
ALDH1A1 P00352 2/20 0.35
MAPT P10636 2/20 0.35
HPGD P15428 2/20 0.35
KMT2A Q03164 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24264241 0.99 KDM4E (0.40) PLA2G2APLA2G4AKDM4EATML3MBTL1
SCHEMBL24264313 0.99 KDM4E (0.40) PLA2G2APLA2G4AKDM4EATML3MBTL1
SCHEMBL22257995 0.97 L3MBTL1 (0.38) PLA2G2APLA2G4AKDM4EATML3MBTL1
SCHEMBL22257759 0.97 L3MBTL1 (0.38) PLA2G2APLA2G4AKDM4EATML3MBTL1
SCHEMBL22257613 0.97 L3MBTL1 (0.38) PLA2G2APLA2G4AKDM4EATML3MBTL1
SCHEMBL22257951 0.97 L3MBTL1 (0.38) PLA2G2APLA2G4AKDM4EATML3MBTL1
SCHEMBL23558060 0.97 KDM4E (0.38) PLA2G2APLA2G4AKDM4EATML3MBTL1
SCHEMBL22240671 0.97 L3MBTL1 (0.38) PLA2G2APLA2G4AKDM4EATML3MBTL1
SCHEMBL22240672 0.97 L3MBTL1 (0.38) PLA2G2APLA2G4AKDM4EATML3MBTL1
SCHEMBL16185421 0.96 KDM4E (0.41) PLA2G2APLA2G4AKDM4EATML3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210320260-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2021-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210320260-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME CRY1, CYP1A1, TRPC1 PLA2G2A 3896/4885PLA2G4A 4007/4885KDM4E 2437/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.